Frontiers in Oncology | Pediatric Oncology

Review

Published on 22 Feb 2024

Historical context, process, and development trends of pediatric thyroid cancer research: a bibliometric analysis

in Pediatric Oncology

Chang Song
Jia-Yuan Luo
Yu-Yan Pang
Rong-Quan He
Xiao-Jiao Li
Gang Chen
Chun-Yan Zhao
Ning Qu
Yan-Mei Chen
Li Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1340872

4,081 views
1 citation

Original Research

Published on 02 Feb 2024

Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside

in Pediatric Oncology

Illya Martynov
Lajwanti Dhaka
Benedikt Wilke
Paul Hoyer
M. Reza Vahdad
Guido Seitz

Frontiers in Oncology

doi 10.3389/fonc.2024.1333129

4,380 views
2 citations

Original Research

Published on 31 Jan 2024

Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden

in Pediatric Oncology

Sofia Wallin
Ingrid Øra
Gabriela Prochazka
Johanna Sandgren
Caroline Björklund
Gustaf Ljungman
Hartmut Vogt
Torben Ek
Cornelis M. van Tilburg
Anna Nilsson

Frontiers in Oncology

doi 10.3389/fonc.2024.1340099

2,957 views

Brief Research Report

Published on 31 Jan 2024

YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells

in Pediatric Oncology

Anna Josefine von Ofen
Uwe Thiel
Jennifer Eck
Hendrik Gassmann
Melanie Thiede
Julia Hauer
Per Sonne Holm
Sebastian J. Schober

Frontiers in Oncology

doi 10.3389/fonc.2024.1304374

4,131 views
1 citation

Clinical Trial

Published on 31 Jan 2024

PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults

in Pediatric Oncology

Nicola Fenwick
Rebekah Weston
Keith Wheatley
Jodie Hodgson
Lynley Marshall
Martin Elliott
Guy Makin
Antony Ng
Bernadette Brennan
Stephen Lowis

Frontiers in Oncology

doi 10.3389/fonc.2024.1296576

4,032 views
10 citations

Case Report

Published on 29 Jan 2024

Diffuse infantile hepatic hemangioma successfully treated with propranolol orally: a case report and literature review

in Pediatric Oncology

Zengyan Li
Zhiming Wu
Youhong Dong
Xiaojun Yuan
Dongdong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1336742

3,374 views
2 citations

Mini Review

Published on 19 Jan 2024

Mast cell in infantile hemangioma

in Pediatric Oncology

Meng Xia
Wenying Liu
Fang Hou

Frontiers in Oncology

doi 10.3389/fonc.2024.1304478

3,466 views
3 citations

Original Research

Published on 17 Jan 2024

Prognostic factors of pediatric ependymomas at a National Cancer Reference Center in Peru

in Pediatric Oncology

Eduardo Perez-Roca
Tatiana Negreiros
Sandro Casavilca-Zambrano
Luis Ojeda-Medina
Rosdali Díaz-Coronado

Frontiers in Oncology

doi 10.3389/fonc.2023.1331790

2,937 views
1 citation

Case Report

Published on 08 Jan 2024

Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia

in Pediatric Oncology

Francesco Fabozzi
Rosalba Carrozzo
Mariachiara Lodi
Angela Di Giannatale
Selene Cipri
Chiara Rosignoli
Isabella Giovannoni
Alessandra Stracuzzi
Teresa Rizza
Claudio Montante

Frontiers in Oncology

doi 10.3389/fonc.2023.1324013

3,062 views
2 citations

Case Report

Published on 20 Dec 2023

Case report: Primary pleural low-grade fibromyxoid sarcoma in a 4-year-old boy with molecular confirmation

in Pediatric Oncology

Xiangni He
Wenyi Jing
Xin He
Min Chen
Hongying Zhang

Frontiers in Oncology

doi 10.3389/fonc.2023.1269078

2,685 views
3 citations

Editorial

Published on 14 Dec 2023

Editorial: Pediatric diencephalic tumors: a constellation of entities and management modalities

in Pediatric Oncology

Antonella Cacchione
Andrea Carai
Veronica Biassoni
Angela Mastronuzzi
Sabina Vennarini

Frontiers in Oncology

doi 10.3389/fonc.2023.1346803

1,458 views

Original Research

Published on 11 Dec 2023

Growth differentiation factor 15 (GDF15) elevation in children with newly diagnosed cancer

in Pediatric Oncology

Daniel V. Runco
Linda A. DiMeglio
Charles P. Vanderpool
Yan Han
Joanne Daggy
Mary M. Kelley
Raya Mikesell
Teresa A. Zimmers

Frontiers in Oncology

doi 10.3389/fonc.2023.1295228

5,400 views
7 citations

Mini Review

Published on 07 Dec 2023

Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases

in Pediatric Oncology

Selene Cipri
Francesco Fabozzi
Giada Del Baldo
Giuseppe Maria Milano
Luigi Boccuto
Andrea Carai
Angela Mastronuzzi

Frontiers in Oncology

doi 10.3389/fonc.2023.1235794

3,032 views

Case Report

Published on 29 Nov 2023

Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapy

in Pediatric Oncology

Federica D’Antonio
Sabrina Rossi
Isabella Giovannoni
Rita Alaggio
Andrea Carai
Giuseppe M. Milano
Antonella Cacchione
Alessandra Cancellieri
Marco Gessi
Manila Antonelli

Frontiers in Oncology

doi 10.3389/fonc.2023.1203994

5,185 views
4 citations

Correction

Published on 27 Nov 2023

Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

in Pediatric Oncology

Ema Mosleh
Stacy Snyder
Ningying Wu
Daniel N. Willis
Rema Malone
Robert J. Hayashi

Frontiers in Oncology

doi 10.3389/fonc.2023.1333273

1,409 views
1 citation

Original Research

Published on 02 Nov 2023

PIWIL1 gene polymorphism and pediatric acute lymphoblastic leukemia relapse susceptibility among Chinese children: a five-center case–control study

in Pediatric Oncology

Wenjiao Ding
Dao Wang
Mansi Cai
Yaping Yan
Shanshan Liu
Xiaodan Liu
Ailing Luo
Decheng Deng
Xiaoping Liu
Hua Jiang

Frontiers in Oncology

doi 10.3389/fonc.2023.1203002

2,407 views
2 citations

Case Report

Published on 01 Nov 2023

Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia

in Pediatric Oncology

Sumit Gupta
Jessica Casey
Joseph Lasky

Frontiers in Oncology

doi 10.3389/fonc.2023.1246924

6,671 views
4 citations

Original Research

Published on 30 Oct 2023

PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma

in Pediatric Oncology

Karim Al-Ghazzawi
Michael Wessolly
Sami Dalbah
Petra Ketteler
Tobias Kiefer
Nikolaos Bechrakis
Jabbarli Leyla
Saskia Ting
Eva Biewald
Fabian D. Mairinger

Frontiers in Oncology

doi 10.3389/fonc.2023.1144951

2,877 views
4 citations

Perspective

Published on 30 Oct 2023

Pediatric precision oncology: “better three hours too soon than a minute too late”

in Pediatric Oncology

Mark Marshall
Jennifer Ivanovich
Morgan Schmitt
Amy Helvie
Lisa Langsford
Jennifer Casterline
Michael Ferguson

Frontiers in Oncology

doi 10.3389/fonc.2023.1279953

2,749 views
3 citations

Original Research

Published on 27 Oct 2023

Invasive fungal infections in pediatric patients with central nervous system tumors: novel insights for prophylactic treatments?

in Pediatric Oncology

Natália Dassi
Andrea Maria Cappellano
Adriana Maria Paixão de Sousa da Silva
Nasjla Saba da Silva
Fabianne Altruda de Moraes Costa Carlesse

Frontiers in Oncology

doi 10.3389/fonc.2023.1248082

2,732 views
1 citation

Systematic Review

Published on 27 Oct 2023

A systematic review of data sources for artificial intelligence applications in pediatric brain tumors in Europe: implications for bias and generalizability

in Pediatric Oncology

Alberto Eugenio Tozzi
Ileana Croci
Paul Voicu
Francesco Dotta
Giovanna Stefania Colafati
Andrea Carai
Francesco Fabozzi
Giuseppe Lacanna
Roberto Premuselli
Angela Mastronuzzi

Frontiers in Oncology

doi 10.3389/fonc.2023.1285775

4,019 views
7 citations

Original Research

Published on 26 Oct 2023

Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

in Pediatric Oncology

Ema Mosleh
Stacy Snyder
Ningying Wu
Daniel N. Willis
Rema Malone
Robert J. Hayashi

Frontiers in Oncology

doi 10.3389/fonc.2023.1280587

5,941 views
14 citations

Retraction

Published on 26 Oct 2023

Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

in Pediatric Oncology

Frontiers Editorial Office

Frontiers in Oncology

doi 10.3389/fonc.2023.1301668

2,575 views

Original Research

Published on 13 Oct 2023

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy

in Pediatric Oncology

Chen Zheng
Shiru Ye
Wei Liu
Mei Diao
Long Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1276175

2,984 views
12 citations

665 articles

articles

Historical context, process, and development trends of pediatric thyroid cancer research: a bibliometric analysis

Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside

Implementing data on targeted therapy from the INFORM registry platform for children with relapsed cancer in Sweden

YB-1-based oncolytic virotherapy in combination with CD47 blockade enhances phagocytosis of pediatric sarcoma cells

PARC: a phase I/II study evaluating the safety and activity of pegylated recombinant human arginase BCT-100 in relapsed/refractory cancers of children and young adults

Diffuse infantile hepatic hemangioma successfully treated with propranolol orally: a case report and literature review

Mast cell in infantile hemangioma

Prognostic factors of pediatric ependymomas at a National Cancer Reference Center in Peru

Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia

Case report: Primary pleural low-grade fibromyxoid sarcoma in a 4-year-old boy with molecular confirmation

Editorial: Pediatric diencephalic tumors: a constellation of entities and management modalities

Growth differentiation factor 15 (GDF15) elevation in children with newly diagnosed cancer

Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases

Case Report: Remarkable breakthrough: successful treatment of a rare intracranial mesenchymal, FET::CREB fusion-positive tumor treated with patient-tailored multimodal therapy

Corrigendum: Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

PIWIL1 gene polymorphism and pediatric acute lymphoblastic leukemia relapse susceptibility among Chinese children: a five-center case–control study

Case Report: Blinatumomab as upfront consolidation and maintenance therapy in a pediatric patient with high-risk B-cell acute lymphoblastic leukemia

PDGF, NGF, and EGF as main contributors to tumorigenesis in high-risk retinoblastoma

Pediatric precision oncology: “better three hours too soon than a minute too late”

Invasive fungal infections in pediatric patients with central nervous system tumors: novel insights for prophylactic treatments?

A systematic review of data sources for artificial intelligence applications in pediatric brain tumors in Europe: implications for bias and generalizability

Factors influencing delayed clearance of high dose methotrexate (HDMTX) in pediatric, adolescent, and young adult oncology patients

Retraction: Identification of hub genes and construction of prognostic nomogram for patients with Wilms tumors

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy